Americans are demanding to know how the US Food and Drug Administration makes its decisions about the medicine they take and the food they consume.
If you value your privacy, it’s urgent that you realize how mandatory health insurance coverage could give others full access to your medical records.
Bayer Healthcare could face a lawsuit in the US over its claim that selenium may reduce the risk of prostate cancer. Bayer makes that claim on advertisements and labels for its One A Day Men’s multivitamin.
Mark Hyman, MD—author, practitioner, and educator in functional medicine—has hit the pavement in Washington, DC, to educate lawmakers and policymakers that universal healthcare coverage based on an “outdated 19th- and 20th-century model of medicine will lead us into danger.” In his Huffington Post article, “How to Fix Obama’s Health Plan Before It’s Too Late,” Dr. […]
We want to start this edition of Pulse of Health Freedom with our hearty thanks for sending Congress your messages on HR2749, the Waxman–Dingell bill (also known as the Food Safety Enhancement Act of 2009, or FSEA), which was the focus of last week’s newsletter. Thousands of messages poured in, and we are tremendously grateful […]
A new, long-awaited food safety bill is now before the US House of Representatives. It is the Food Safety Enhancement Act of 2009, or FSEA. Introduced by Reps. Henry Waxman (D–CA) and John Dingell (D–MI), the FSEA is meant to address food safety concerns. But as you will see, much of it is not about […]
According to Deborah Swackhamer, an environmental health professor at the University of Minnesota, “Hormones at very small doses regulate just about everything, and if you’ve got chemicals that can mimic that, they can mess with growth, behavior, and development.” Just last month, Minnesota banned the chemical bisphenol A (BPA) from baby bottles and sippy cups. […]
Pharmaceutical companies have figured out that the FDA can be reshaped into a tool to increase their profits instead of doing its actual job—screening drugs for safety on behalf of consumers. First, there was the pharmaceutical company assault on your access to vitamin B6. The FDA has now ended your access to one of the […]
The June 16 edition of Pulse of Health Freedom discussed the suspension of the NIH-sponsored clinical trial for chelation therapy known as the TACT study. The study’s investigators and coordinators have now been notified to resume all TACT activities, including the chelation infusions, patient follow-up, and vitamin distribution.
The Celebrex and Vioxx debacle, the Rezulin recall, and many other problems have raised concerns about the FDA’s ability to address prescription drug safety. Whistleblowers, including FDA drug researcher David Graham, have made national headlines with Congressional testimony taking the FDA to task.